Fenbendazole Case Reports: 3 Stage IV Cancers in Remission (2025 Case Series)
A 2025 peer-reviewed case series documented complete or near-complete remission in three Stage IV cancer patients using fenbendazole. We walk through each case timeline, the biomarker data, the Karger retraction controversy, and what these reports actually prove.
